MENU
RNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Atrium Therapeutics (RNA) Earnings Date & Reports
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies... Show more
A.I. Advisor
published Earnings
RNA is expected to report earnings to rise 33.86% to -170 cents per share on November 12
Q3'26
Est.
$-1.70
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.25
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.80
The last earnings report on November 10 showed earnings per share of -126 cents, missing the estimate of -113 cents. With 84.85K shares outstanding, the current market capitalization sits at 136.85M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a company which engages in the research and development of biopharmaceutical products
Industry Biotechnology
Industry
N/A
Address
10578 Science Center Drive
Phone
+1 619 876-0700
Employees
N/A
Web
N/A